0001736361-18-000001.txt : 20180405 0001736361-18-000001.hdr.sgml : 20180405 20180405100405 ACCESSION NUMBER: 0001736361-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180405 DATE AS OF CHANGE: 20180405 EFFECTIVENESS DATE: 20180405 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acworth Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001736361 IRS NUMBER: 814610456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-309386 FILM NUMBER: 18739527 BUSINESS ADDRESS: STREET 1: 12 OHIO AVE. CITY: NEWTON STATE: MA ZIP: 02464 BUSINESS PHONE: 617-529-0160 MAIL ADDRESS: STREET 1: 12 OHIO AVE. CITY: NEWTON STATE: MA ZIP: 02464 D 1 primary_doc.xml X0708 D LIVE 0001736361 Acworth Pharmaceuticals, Inc. 12 OHIO AVE. NEWTON MA MASSACHUSETTS 02464 617-529-0160 DELAWARE None None Corporation true 2016 Edward W. Marple 12 Ohio Ave. Newton MA MASSACHUSETTS 02464 Executive Officer Director Promoter Jack Leonard 12 Ohio Ave. Newton MA MASSACHUSETTS 02464 Promoter Biotechnology Decline to Disclose 06b false true false true false 0 2000000 0 2000000 false 0 0 0 0 Proceeds will be used for working capital, which may include normal compensation to executive officers. false Acworth Pharmaceuticals, Inc. /s/ Edward W. Marple Edward W. Marple President and CEO 2018-04-04